🇺🇸 Lamivudine, zidovudine, nevirapine in United States

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Lamivudine, zidovudine, nevirapine (Lamivudine, zidovudine, nevirapine) regulatory status in United States.

Marketing authorisation

FDA

Application: NDA021971
Marketing authorisation holder: CIPLA LIMITED
Local brand name: LAMIVUDINE; ZIDOVUDINE; NEVIRAPINE
Indication: TABLET — ORAL
Status: approved

Read official source →

Frequently asked questions

Is Lamivudine, zidovudine, nevirapine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Lamivudine, zidovudine, nevirapine in United States?

CIPLA LIMITED holds the US marketing authorisation.